Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 17 entries
Sorted by: Best Match Show Resources per page
Oxidative Distress Induces Wnt/β-Catenin Pathway Modulation in Colorectal Cancer Cells: Perspectives on APC Retained Functions.

Cancers

Catalano T, D'Amico E, Moscatello C, Di Marcantonio MC, Ferrone A, Bologna G, Selvaggi F, Lanuti P, Cotellese R, Curia MC, Lattanzio R, Aceto GM.
PMID: 34885156
Cancers (Basel). 2021 Nov 30;13(23). doi: 10.3390/cancers13236045.

Colorectal cancer (CRC) is a multistep process that arises in the colic tissue microenvironment. Oxidative stress plays a role in mediating CRC cell survival and progression, as well as promoting resistance to therapies. CRC progression is associated with Wnt/β-Catenin...

Cite
Catalano T, D'Amico E, Moscatello C, et al. Oxidative Distress Induces Wnt/β-Catenin Pathway Modulation in Colorectal Cancer Cells: Perspectives on APC Retained Functions. Cancers (Basel). 2021;13(23)doi: 10.3390/cancers13236045.
Catalano, T., D'Amico, E., Moscatello, C., Di Marcantonio, M. C., Ferrone, A., Bologna, G., Selvaggi, F., Lanuti, P., Cotellese, R., Curia, M. C., Lattanzio, R., & Aceto, G. M. (2021). Oxidative Distress Induces Wnt/β-Catenin Pathway Modulation in Colorectal Cancer Cells: Perspectives on APC Retained Functions. Cancers, 13(23), . https://doi.org/10.3390/cancers13236045
Catalano, Teresa, et al. "Oxidative Distress Induces Wnt/β-Catenin Pathway Modulation in Colorectal Cancer Cells: Perspectives on APC Retained Functions." Cancers vol. 13,23 (2021). doi: https://doi.org/10.3390/cancers13236045
Catalano T, D'Amico E, Moscatello C, Di Marcantonio MC, Ferrone A, Bologna G, Selvaggi F, Lanuti P, Cotellese R, Curia MC, Lattanzio R, Aceto GM. Oxidative Distress Induces Wnt/β-Catenin Pathway Modulation in Colorectal Cancer Cells: Perspectives on APC Retained Functions. Cancers (Basel). 2021 Nov 30;13(23). doi: 10.3390/cancers13236045. PMID: 34885156.
Copy Download .nbib Format: NLM
Laparoscopic and open complete mesocolic excision with central vascular ligation for right colonic adenocarcinoma: a retrospective comparative study.

ANZ journal of surgery

Testa DC, Mazzola L, di Martino G, Cotellese R, Selvaggi F.
PMID: 34636465
ANZ J Surg. 2021 Oct 12; doi: 10.1111/ans.17264. Epub 2021 Oct 12.

BACKGROUND: To examine the outcome of patients treated with complete mesocolic excision (CME) with central vascular ligation (CVL) after conventional and laparoscopic surgery.METHODS: We retrospectively evaluated stage I-IV colon adenocarcinoma patients treated by the same surgeon (L.M.) from 2013...

Cite
Testa DC, Mazzola L, di Martino G, et al. Laparoscopic and open complete mesocolic excision with central vascular ligation for right colonic adenocarcinoma: a retrospective comparative study. ANZ J Surg. 2021;doi: 10.1111/ans.17264.
Testa, D. C., Mazzola, L., di Martino, G., Cotellese, R., & Selvaggi, F. (2021). Laparoscopic and open complete mesocolic excision with central vascular ligation for right colonic adenocarcinoma: a retrospective comparative study. ANZ journal of surgery, . https://doi.org/10.1111/ans.17264
Testa, Domenica Carmen, et al. "Laparoscopic and open complete mesocolic excision with central vascular ligation for right colonic adenocarcinoma: a retrospective comparative study." ANZ journal of surgery vol. (2021). doi: https://doi.org/10.1111/ans.17264
Testa DC, Mazzola L, di Martino G, Cotellese R, Selvaggi F. Laparoscopic and open complete mesocolic excision with central vascular ligation for right colonic adenocarcinoma: a retrospective comparative study. ANZ J Surg. 2021 Oct 12; doi: 10.1111/ans.17264. Epub 2021 Oct 12. PMID: 34636465.
Copy Download .nbib Format: NLM
The Potential of Colonic Tumor Tissue .

Cancers

Pignatelli P, Iezzi L, Pennese M, Raimondi P, Cichella A, Bondi D, Grande R, Cotellese R, Di Bartolomeo N, Innocenti P, Piattelli A, Curia MC.
PMID: 33804585
Cancers (Basel). 2021 Mar 01;13(5). doi: 10.3390/cancers13051032.

BACKGROUND: Intestinal microbiota dysbiosis may enhance the carcinogenicity of colon cancer (CC) by the proliferation and differentiation of epithelial cells. Oral METHODS: Thirty-six CC patients were included in the study to assess the RESULTS: Patients had a greater quantity...

Cite
Pignatelli P, Iezzi L, Pennese M, et al. The Potential of Colonic Tumor Tissue . Cancers (Basel). 2021;13(5)doi: 10.3390/cancers13051032.
Pignatelli, P., Iezzi, L., Pennese, M., Raimondi, P., Cichella, A., Bondi, D., Grande, R., Cotellese, R., Di Bartolomeo, N., Innocenti, P., Piattelli, A., & Curia, M. C. (2021). The Potential of Colonic Tumor Tissue . Cancers, 13(5), . https://doi.org/10.3390/cancers13051032
Pignatelli, Pamela, et al. "The Potential of Colonic Tumor Tissue ." Cancers vol. 13,5 (2021). doi: https://doi.org/10.3390/cancers13051032
Pignatelli P, Iezzi L, Pennese M, Raimondi P, Cichella A, Bondi D, Grande R, Cotellese R, Di Bartolomeo N, Innocenti P, Piattelli A, Curia MC. The Potential of Colonic Tumor Tissue . Cancers (Basel). 2021 Mar 01;13(5). doi: 10.3390/cancers13051032. PMID: 33804585; PMCID: PMC7957509.
Copy Download .nbib Format: NLM
Anthocran® Phytosome®: Prevention of Recurring Urinary Infections and Symptoms after Catheterization.

Journal of dietary supplements

Cotellese R, Ledda A, Belcaro G, Cesarone MR, Scipione C, Scipione V, Dugall M, Feragalli B, Riva A, Allegrini P, Petrangolini G, Togni S.
PMID: 34632933
J Diet Suppl. 2021 Oct 10;1-13. doi: 10.1080/19390211.2021.1972074. Epub 2021 Oct 10.

In this preliminary pilot registry study, we investigated the effects of the oral supplementation of a standardized cranberry extract (Anthocran® Phytosome®, Indena) delivered by a lecithin-based system, for the prophylactic management of recurrent-urinary tract infections (R-UTIs). We included 64...

Cite
Cotellese R, Ledda A, Belcaro G, et al. Anthocran® Phytosome®: Prevention of Recurring Urinary Infections and Symptoms after Catheterization. J Diet Suppl. 2021;1-13doi: 10.1080/19390211.2021.1972074.
Cotellese, R., Ledda, A., Belcaro, G., Cesarone, M. R., Scipione, C., Scipione, V., Dugall, M., Feragalli, B., Riva, A., Allegrini, P., Petrangolini, G., & Togni, S. (2021). Anthocran® Phytosome®: Prevention of Recurring Urinary Infections and Symptoms after Catheterization. Journal of dietary supplements, 1-13. https://doi.org/10.1080/19390211.2021.1972074
Cotellese, Roberto, et al. "Anthocran® Phytosome®: Prevention of Recurring Urinary Infections and Symptoms after Catheterization." Journal of dietary supplements vol. (2021): 1-13. doi: https://doi.org/10.1080/19390211.2021.1972074
Cotellese R, Ledda A, Belcaro G, Cesarone MR, Scipione C, Scipione V, Dugall M, Feragalli B, Riva A, Allegrini P, Petrangolini G, Togni S. Anthocran® Phytosome®: Prevention of Recurring Urinary Infections and Symptoms after Catheterization. J Diet Suppl. 2021 Oct 10;1-13. doi: 10.1080/19390211.2021.1972074. Epub 2021 Oct 10. PMID: 34632933.
Copy Download .nbib Format: NLM
Prevention of work-related stress, fatigue, loss of cognitive function, attention and recovery of stamina with Robuvit® in professionals with increased oxidative stress.

Minerva medica

Belcaro G, Cesarone MR, Saggino A, Dugall M, Hu S, Scipione C, Scipione V, Cornelli U, Hosoi M, Cotellese R, Cox D, Corsi M, Feragalli B.
PMID: 34542952
Minerva Med. 2021 Sep 20; doi: 10.23736/S0026-4806.21.07776-4. Epub 2021 Sep 20.

AIM: The aim of this open, pilot supplement registry study was to evaluate the protective, preventive effects of Robuvit® on professional-related fatigue symptoms and on aspects of cognitive functions, professional attitudes and decision-making in healthy nurses under professional stress...

Cite
Belcaro G, Cesarone MR, Saggino A, et al. Prevention of work-related stress, fatigue, loss of cognitive function, attention and recovery of stamina with Robuvit® in professionals with increased oxidative stress. Minerva Med. 2021;doi: 10.23736/S0026-4806.21.07776-4.
Belcaro, G., Cesarone, M. R., Saggino, A., Dugall, M., Hu, S., Scipione, C., Scipione, V., Cornelli, U., Hosoi, M., Cotellese, R., Cox, D., Corsi, M., & Feragalli, B. (2021). Prevention of work-related stress, fatigue, loss of cognitive function, attention and recovery of stamina with Robuvit® in professionals with increased oxidative stress. Minerva medica, . https://doi.org/10.23736/S0026-4806.21.07776-4
Belcaro, Gianni, et al. "Prevention of work-related stress, fatigue, loss of cognitive function, attention and recovery of stamina with Robuvit® in professionals with increased oxidative stress." Minerva medica vol. (2021). doi: https://doi.org/10.23736/S0026-4806.21.07776-4
Belcaro G, Cesarone MR, Saggino A, Dugall M, Hu S, Scipione C, Scipione V, Cornelli U, Hosoi M, Cotellese R, Cox D, Corsi M, Feragalli B. Prevention of work-related stress, fatigue, loss of cognitive function, attention and recovery of stamina with Robuvit® in professionals with increased oxidative stress. Minerva Med. 2021 Sep 20; doi: 10.23736/S0026-4806.21.07776-4. Epub 2021 Sep 20. PMID: 34542952.
Copy Download .nbib Format: NLM
Minimally Invasive Treatment of Sporadic Burkitt's Lymphoma Causing Ileocaecal Invagination.

Case reports in surgery

Panaccio P, Fiordaliso M, Testa D, Mazzola L, Battilana M, Cotellese R, Selvaggi F.
PMID: 29854542
Case Rep Surg. 2018 Apr 30;2018:6265182. doi: 10.1155/2018/6265182. eCollection 2018.

INTRODUCTION: Primary NHL (non-Hodgkin lymphoma) of the colon represents only 0.2% to 1.2% of all colonic malignancies. Burkitt's lymphoma (BL) is usually a disease reported in children and young people, most of them associated with EBV or HIV infection....

Cite
Panaccio P, Fiordaliso M, Testa D, et al. Minimally Invasive Treatment of Sporadic Burkitt's Lymphoma Causing Ileocaecal Invagination. Case Rep Surg. 2018;2018:6265182doi: 10.1155/2018/6265182.
Panaccio, P., Fiordaliso, M., Testa, D., Mazzola, L., Battilana, M., Cotellese, R., & Selvaggi, F. (2018). Minimally Invasive Treatment of Sporadic Burkitt's Lymphoma Causing Ileocaecal Invagination. Case reports in surgery, 20186265182. https://doi.org/10.1155/2018/6265182
Panaccio, Paolo, et al. "Minimally Invasive Treatment of Sporadic Burkitt's Lymphoma Causing Ileocaecal Invagination." Case reports in surgery vol. 2018 (2018): 6265182. doi: https://doi.org/10.1155/2018/6265182
Panaccio P, Fiordaliso M, Testa D, Mazzola L, Battilana M, Cotellese R, Selvaggi F. Minimally Invasive Treatment of Sporadic Burkitt's Lymphoma Causing Ileocaecal Invagination. Case Rep Surg. 2018 Apr 30;2018:6265182. doi: 10.1155/2018/6265182. eCollection 2018. PMID: 29854542; PMCID: PMC5952441.
Copy Download .nbib Format: NLM
Pycnogenol® Supplementation Prevents Recurrent Urinary Tract Infections/Inflammation and Interstitial Cystitis.

Evidence-based complementary and alternative medicine : eCAM

Ledda A, Hu S, Cesarone MR, Belcaro G, Dugall M, Feragalli B, Cotellese R, Hosoi M, Ippolito E, Corsi M, Luzzi R.
PMID: 34257695
Evid Based Complement Alternat Med. 2021 Jun 23;2021:9976299. doi: 10.1155/2021/9976299. eCollection 2021.

This open pilot registry study aimed to evaluate and compare the prophylactic effects of Pycnogenol® or cranberry extract in subjects with previous, recurrent urinary tract infections (UTI) or interstitial cystitis (IC).

Cite
Ledda A, Hu S, Cesarone MR, et al. Pycnogenol® Supplementation Prevents Recurrent Urinary Tract Infections/Inflammation and Interstitial Cystitis. Evid Based Complement Alternat Med. 2021;2021:9976299doi: 10.1155/2021/9976299.
Ledda, A., Hu, S., Cesarone, M. R., Belcaro, G., Dugall, M., Feragalli, B., Cotellese, R., Hosoi, M., Ippolito, E., Corsi, M., & Luzzi, R. (2021). Pycnogenol® Supplementation Prevents Recurrent Urinary Tract Infections/Inflammation and Interstitial Cystitis. Evidence-based complementary and alternative medicine : eCAM, 20219976299. https://doi.org/10.1155/2021/9976299
Ledda, A, et al. "Pycnogenol® Supplementation Prevents Recurrent Urinary Tract Infections/Inflammation and Interstitial Cystitis." Evidence-based complementary and alternative medicine : eCAM vol. 2021 (2021): 9976299. doi: https://doi.org/10.1155/2021/9976299
Ledda A, Hu S, Cesarone MR, Belcaro G, Dugall M, Feragalli B, Cotellese R, Hosoi M, Ippolito E, Corsi M, Luzzi R. Pycnogenol® Supplementation Prevents Recurrent Urinary Tract Infections/Inflammation and Interstitial Cystitis. Evid Based Complement Alternat Med. 2021 Jun 23;2021:9976299. doi: 10.1155/2021/9976299. eCollection 2021. PMID: 34257695; PMCID: PMC8249140.
Copy Download .nbib Format: NLM
Pycnogenol® supplementation prevents inflammation and symptoms in recurrent, non-severe urinary infections.

Panminerva medica

Cotellese R, Hu S, Cesarone MR, Belcaro G, Dugall M, Feragalli B, Hosoi M, Ippolito E, Corsi M, Luzzi R.
PMID: 34738775
Panminerva Med. 2021 Sep;63(3):343-348. doi: 10.23736/S0031-0808.20.03853-7.

BACKGROUND: The aim of this pilot, registry study was to evaluate the prophylactic effects of oral supplementation with PycnogenolMETHODS: subjects with recurrent-UTIs, defined by: 1) at least three symptomatic UTIs over the past year; 2) two episodes of UTI's...

Cite
Cotellese R, Hu S, Cesarone MR, et al. Pycnogenol® supplementation prevents inflammation and symptoms in recurrent, non-severe urinary infections. Panminerva Med. 2021;63(3):343-348doi: 10.23736/S0031-0808.20.03853-7.
Cotellese, R., Hu, S., Cesarone, M. R., Belcaro, G., Dugall, M., Feragalli, B., Hosoi, M., Ippolito, E., Corsi, M., & Luzzi, R. (2021). Pycnogenol® supplementation prevents inflammation and symptoms in recurrent, non-severe urinary infections. Panminerva medica, 63(3), 343-348. https://doi.org/10.23736/S0031-0808.20.03853-7
Cotellese, Roberto, et al. "Pycnogenol® supplementation prevents inflammation and symptoms in recurrent, non-severe urinary infections." Panminerva medica vol. 63,3 (2021): 343-348. doi: https://doi.org/10.23736/S0031-0808.20.03853-7
Cotellese R, Hu S, Cesarone MR, Belcaro G, Dugall M, Feragalli B, Hosoi M, Ippolito E, Corsi M, Luzzi R. Pycnogenol® supplementation prevents inflammation and symptoms in recurrent, non-severe urinary infections. Panminerva Med. 2021 Sep;63(3):343-348. doi: 10.23736/S0031-0808.20.03853-7. PMID: 34738775.
Copy Download .nbib Format: NLM
Primary benign back pain: supplementation with Pycnogenol®.

Panminerva medica

Cox D, Belcaro G, Cesarone MR, Cotellese R, Dugall M, Feragalli B, Hosoi M, Corsi M, Luzzi R.
PMID: 34915691
Panminerva Med. 2021 Dec;63(4):472-477. doi: 10.23736/S0031-0808.20.03961-0.

BACKGROUND: Back pain (BP) is one of the most common problems seen by general practitioners. The aim of this pilot registry study was to evaluate the effects of PycnogenolMETHODS: The registry follow-up lasted 3 weeks. Subjects used either SM...

Cite
Cox D, Belcaro G, Cesarone MR, et al. Primary benign back pain: supplementation with Pycnogenol®. Panminerva Med. 2021;63(4):472-477doi: 10.23736/S0031-0808.20.03961-0.
Cox, D., Belcaro, G., Cesarone, M. R., Cotellese, R., Dugall, M., Feragalli, B., Hosoi, M., Corsi, M., & Luzzi, R. (2021). Primary benign back pain: supplementation with Pycnogenol®. Panminerva medica, 63(4), 472-477. https://doi.org/10.23736/S0031-0808.20.03961-0
Cox, David, et al. "Primary benign back pain: supplementation with Pycnogenol®." Panminerva medica vol. 63,4 (2021): 472-477. doi: https://doi.org/10.23736/S0031-0808.20.03961-0
Cox D, Belcaro G, Cesarone MR, Cotellese R, Dugall M, Feragalli B, Hosoi M, Corsi M, Luzzi R. Primary benign back pain: supplementation with Pycnogenol®. Panminerva Med. 2021 Dec;63(4):472-477. doi: 10.23736/S0031-0808.20.03961-0. PMID: 34915691.
Copy Download .nbib Format: NLM
Supplementary management of functional, hepatic damage with Liverubin (pharma-standard Silymarin). A 3-month registry.

Minerva gastroenterologica e dietologica

Pellegrini L, Belcaro G, Dugall M, Hu S, Gizzi G, Corsi M, Hosoi M, Luzzi R, Feragalli B, Cotellese R.
PMID: 26448308
Minerva Gastroenterol Dietol. 2015 Oct 08; Epub 2015 Oct 08.

Mild, temporary hepatic failure (MTHF) is a common clinical problem; in case of repeated episodes MTHF may cause chronic liver impairment. This registry has evaluated MTHF in subjects using Liverubin (standardized Silymarin) for 8 weeks.METHODS: MTHF was evaluated in...

Cite
Pellegrini L, Belcaro G, Dugall M, et al. Supplementary management of functional, hepatic damage with Liverubin (pharma-standard Silymarin). A 3-month registry. Minerva Gastroenterol Dietol. 2015;
Pellegrini, L., Belcaro, G., Dugall, M., Hu, S., Gizzi, G., Corsi, M., Hosoi, M., Luzzi, R., Feragalli, B., & Cotellese, R. (2015). Supplementary management of functional, hepatic damage with Liverubin (pharma-standard Silymarin). A 3-month registry. Minerva gastroenterologica e dietologica, .
Pellegrini, L, et al. "Supplementary management of functional, hepatic damage with Liverubin (pharma-standard Silymarin). A 3-month registry." Minerva gastroenterologica e dietologica vol. (2015).
Pellegrini L, Belcaro G, Dugall M, Hu S, Gizzi G, Corsi M, Hosoi M, Luzzi R, Feragalli B, Cotellese R. Supplementary management of functional, hepatic damage with Liverubin (pharma-standard Silymarin). A 3-month registry. Minerva Gastroenterol Dietol. 2015 Oct 08; Epub 2015 Oct 08. PMID: 26448308.
Copy Download .nbib Format: NLM
Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin).

Minerva gastroenterologica e dietologica

Pellegrini L, Belcaro G, Dugall M, Hu S, Gizzi G, Corsi M, Hosoi M, Luzzi R, Feragalli B, Cotellese R.
PMID: 26492585
Minerva Gastroenterol Dietol. 2015 Oct 22; Epub 2015 Oct 22.

Mild, temporary hepatic failure (MTHF) after chemotherapy is a common clinical problem; in case of repeated episodes MTHF may cause chronic impairment. This registry has evaluated post- chemotherapy (PC)-MTHF in subjects using Liverubin (standardized Silymarin) for 8 weeks (3...

Cite
Pellegrini L, Belcaro G, Dugall M, et al. Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin). Minerva Gastroenterol Dietol. 2015;
Pellegrini, L., Belcaro, G., Dugall, M., Hu, S., Gizzi, G., Corsi, M., Hosoi, M., Luzzi, R., Feragalli, B., & Cotellese, R. (2015). Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin). Minerva gastroenterologica e dietologica, .
Pellegrini, L, et al. "Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin)." Minerva gastroenterologica e dietologica vol. (2015).
Pellegrini L, Belcaro G, Dugall M, Hu S, Gizzi G, Corsi M, Hosoi M, Luzzi R, Feragalli B, Cotellese R. Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin). Minerva Gastroenterol Dietol. 2015 Oct 22; Epub 2015 Oct 22. PMID: 26492585.
Copy Download .nbib Format: NLM
Preventive effects of Pycnogenol® on cardiovascular risk factors (including endothelial function) and microcirculation in subjects recovering from coronavirus disease 2019 (COVID-19).

Minerva medica

Belcaro G, Cornelli U, Cesarone MR, Scipione C, Scipione V, Hu S, Feragalli B, Corsi M, Cox D, Cotellese R, Hosoi M, Burki C.
PMID: 34060731
Minerva Med. 2021 Jun 01; doi: 10.23736/S0026-4806.21.07650-3. Epub 2021 Jun 01.

BACKGROUND: The aim of this open supplement study was to evaluate the effects of Pycnogenol® in comparison with controls on symptoms of post-COVID-19 syndrome and in improving endothelial function, microcirculation, inflammatory markers and oxidative stress over 3 months in...

Cite
Belcaro G, Cornelli U, Cesarone MR, et al. Preventive effects of Pycnogenol® on cardiovascular risk factors (including endothelial function) and microcirculation in subjects recovering from coronavirus disease 2019 (COVID-19). Minerva Med. 2021;doi: 10.23736/S0026-4806.21.07650-3.
Belcaro, G., Cornelli, U., Cesarone, M. R., Scipione, C., Scipione, V., Hu, S., Feragalli, B., Corsi, M., Cox, D., Cotellese, R., Hosoi, M., & Burki, C. (2021). Preventive effects of Pycnogenol® on cardiovascular risk factors (including endothelial function) and microcirculation in subjects recovering from coronavirus disease 2019 (COVID-19). Minerva medica, . https://doi.org/10.23736/S0026-4806.21.07650-3
Belcaro, Gianni, et al. "Preventive effects of Pycnogenol® on cardiovascular risk factors (including endothelial function) and microcirculation in subjects recovering from coronavirus disease 2019 (COVID-19)." Minerva medica vol. (2021). doi: https://doi.org/10.23736/S0026-4806.21.07650-3
Belcaro G, Cornelli U, Cesarone MR, Scipione C, Scipione V, Hu S, Feragalli B, Corsi M, Cox D, Cotellese R, Hosoi M, Burki C. Preventive effects of Pycnogenol® on cardiovascular risk factors (including endothelial function) and microcirculation in subjects recovering from coronavirus disease 2019 (COVID-19). Minerva Med. 2021 Jun 01; doi: 10.23736/S0026-4806.21.07650-3. Epub 2021 Jun 01. PMID: 34060731.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 17 entries